Menu

#Igalmi

1 post

Feed
1 of 1 post
FDA Clears Teva's Newly Acquired At-Home Agitation Treatment in Schizophrenia and Bipolar Disorder
📰
0Read More

FDA Clears Teva's Newly Acquired At-Home Agitation Treatment in Schizophrenia and Bipolar Disorder

Top Stories Feed·Vandana Singh·about 3 hours ago
#kVBSGW4s
#benzinga#teva#igalmi#disorder#tolerability

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced on Monday that the U.S. Food and Drug Administration (FDA) approved IGALMI (dexmedetomidine) sublingual film for at-home use.…

15s